FDA Unveils Plan To Speed Biosimilar Drugs To Market
By Dan McKay · October 29, 2025, 6:12 PM EDT
The Trump administration on Wednesday said it plans to slash the cost of biologics by shortening the time required to bring a biosimilar drug to market and making it easier for...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login